FDA Inspection 1008484 — Biovectra, Inc.
The FDA completed an inspection of Biovectra, Inc. on Feb 17, 2017 in Charlottetown. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Feb 17, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Charlottetown (Canada)